Progress in leukemias
Dr Guy Sauvageau at the Institute for Research in Immunology and Cancer, Université de Montréal, led a study of 2 forms of acute myeloid leukemia (AML) and identified for the first time a pattern of gene activity shared by these 2 subsets. This new information should advance how AML is diagnosed and how treatments can be tailored to improve survival.
Reference: Nature Genetics, September 2015
Photo credit: Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), www.iric.ca.